FUNCTIONAL MR IN THE EVALUATION OF DEMENTIA - CORRELATION OF ABNORMALDYNAMIC CEREBRAL BLOOD-VOLUME MEASUREMENTS WITH CHANGES IN CEREBRAL METABOLISM ON POSITRON EMISSION TOMOGRAPHY WITH FLUDEOXYGLUCOSE F-18
Rg. Gonzalez et al., FUNCTIONAL MR IN THE EVALUATION OF DEMENTIA - CORRELATION OF ABNORMALDYNAMIC CEREBRAL BLOOD-VOLUME MEASUREMENTS WITH CHANGES IN CEREBRAL METABOLISM ON POSITRON EMISSION TOMOGRAPHY WITH FLUDEOXYGLUCOSE F-18, American journal of neuroradiology, 16(9), 1995, pp. 1763-1770
Citations number
19
Categorie Soggetti
Neurosciences,"Radiology,Nuclear Medicine & Medical Imaging
PURPOSE: To determine whether magnetic susceptibility functional MR im
aging of cerebral blood volumes provides information similar to fludeo
xyglucose F 18 positron emission tomography (PET) brain images in pati
ents undergoing evaluation for dementia. METHODS: Ten subjects were st
udied with both PET and functional MR. Clinical diagnoses included pro
bable Alzheimer disease (n = 5), possible Alzheimer disease (n = 1), P
ick disease (n = 2), and primary progressive aphasia (n = 2). The stud
ies were quantitatively evaluated by coregistration of PET and functio
nal MR images followed by regression analyses of corresponding regions
of interest. Qualitatively, each brain was categorized into eight reg
ions, and each was classified as normal or abnormal by visual inspecti
on. RESULTS: Correlation coefficients between registered functional MR
and PET images were excellent (mean, r = 0.58) in most of the cerebru
m. Significant correlations were observed in 72 of 74 brain sections.
Qualitatively, 16 brain regions were judged to be abnormal by both MR
imaging and PET; 46 regions were normal by both; 10 regions were abnor
mal by PET only; and 8 regions were abnormal only by functional MR. Th
e concordance between functional MR and PET was 78%, which was highly
significant. CONCLUSION: Cerebral blood volumes images derived from ma
gnetic susceptibility (functional MR) provide information similar to f
ludeoxyglucose F 18 PET images in demented patients undergoing evaluat
ion for dementia.